Rebamipide, a gastroprotective drug, was developed in Japan and was accurate to be above to cetraxate, the above a lot of assigned biologic of the aforementioned category, in 1989 in the analysis for belly ulcers.
The initially apparent basal mechanisms of action of rebamipide included its action as a prostaglandin inducer and oxygen free-radical scavenger. In addition, several molecules accept been articular as ameliorative targets of rebamipide to explain its pleiotropic pharmacological actions.
In the endure 5 years, several basal and analytic studies accept been performed for anatomic dyspepsia, abiding gastritis, NSAID-induced gastrointestinal injuries, belly abscess afterward abolishment analysis for Helicobacter pylori, belly abscess afterwards endoscopic anaplasty and ulcerative colitis.
more about: Rebamipide
from: Pharmaceutical Ingredients
No comments:
Post a Comment